| Name | Title | Contact Details |
|---|
Harris Williams has served the middle market for more than 25 years. Our legacy of sell-side execution excellence and market leadership provide a track record of delivering unmatched results for our clients. Our teams of industry-focused investment banking professionals have strong and expansive relationships with buyers and investors around the globe to help our clients realize maximum value for the businesses they have built.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.
Man Group is an active investment management firm focused on delivering performance and client solutions through its five investment management businesses: Man AHL; Man Numeric; Man GLG; Man FRM and Man Global Private Markets. Man Group`s investment management businesses provide long-only, alternative and private markets products on a single and multi-manager basis, leveraging the firm`s robust infrastructure to provide a diverse range of strategies across investment approaches, styles and asset classes. The original business was founded in 1783. Today, Man Group plc is listed on the London Stock Exchange under the ticker EMG.L and is a constituent of the FTSE 250 Index. As at 31 December 2017, Man Group`s funds under management were $109.1 billion. Man Group also supports many awards, charities and initiatives around the world, including sponsorship of the Man Booker literary prizes.
Ballistic Ventures is a venture capital firm solely dedicated to early-stage cybersecurity and cyber-related companies. The partners have spent their entire careers defending against every cyber threat conceivable. Members of the firm have founded, operated, and funded over 90 successful cybersecurity firms – including Abnormal Security, AlienVault, Arbitrum (Offchain Labs), ArcSight, Arkose Labs, Fortify, Interos, ISS, Mandiant, and Shape Security – led over 10,000 security professionals globally, and have 40+ years of experience in venture capital. The Ballistic portfolio includes Alethea, ArmorCode, Concentric AI, Nudge Security, Pangea, Perygee, Talon Cyber Security, and Veza. Our experience provides entrepreneurs impactful support from people focused on the same mission. Our networks and relationships open doors for our founders.
Securian Asset Management provides customized strategies to institutional investors to help achieve our clients’ investment objectives.